ROVIGATTI, UGO
 Distribuzione geografica
Continente #
EU - Europa 463
NA - Nord America 335
AS - Asia 55
Continente sconosciuto - Info sul continente non disponibili 2
Totale 855
Nazione #
US - Stati Uniti d'America 334
PL - Polonia 258
IT - Italia 98
RU - Federazione Russa 38
IE - Irlanda 30
CN - Cina 22
HK - Hong Kong 13
LT - Lituania 10
VN - Vietnam 10
FI - Finlandia 9
SE - Svezia 9
JP - Giappone 6
ES - Italia 4
UA - Ucraina 3
DE - Germania 2
EU - Europa 2
HU - Ungheria 2
IN - India 2
SG - Singapore 2
CA - Canada 1
Totale 855
Città #
Warsaw 258
Fairfield 71
Milan 49
Chandler 35
Dublin 29
Ashburn 28
Woodbridge 27
Moscow 22
Seattle 21
Wilmington 17
Houston 16
Princeton 15
Cambridge 14
Florence 13
Dong Ket 10
Vilnius 10
Boston 9
Altamura 8
Ann Arbor 8
Lawrence 7
Rome 7
Beijing 5
Krasnodar 5
Barcelona 4
Hong Kong 4
San Diego 4
Umeda 4
Boardman 3
Fuzhou 3
Lappeenranta 3
Redwood City 3
Bolzano 2
Decatur 2
Falls Church 2
Hyderabad 2
Nanjing 2
Shanghai 2
Siena 2
Singapore 2
Szigetszentmiklos 2
Wuhan 2
Bellaria-Igea Marina 1
Castelliri 1
Guangzhou 1
Hefei 1
Jinan 1
Kagoya 1
Laurel 1
Los Angeles 1
Lucca 1
Medford 1
Mola Di Bari 1
Nals 1
Parma 1
Phoenix 1
Tokyo 1
Toronto 1
Totale 748
Nome #
The Lesson of Molecular Oncology and Prostate Cancer: Celebrating 50 years of the Nobel Award to P. Rous and C. Huggins 205
The Long Journey of Cancer Modeling: Ubi Sumus? Quo Vadimus? 172
"STATIC VS DYNAMIC MODELS IN CANCER RESEARCH TODAY: new or unanswered questions which still challenge our modeling and understanding of cancer" 86
Cancer modelling in the NGS era - Part I: Emerging technology and initial modelling 86
If Not Now, When? Chloroquine/Hydroxychloroquine dosage for COVID-19 should be clarified especially in view of higher mortality in the elderly. 70
Chronic Fatigue Syndrome (CFS) and Cancer Related Fatigue (CRF): Two " fatigue" syndromes with overlapping symptoms and possibly related aetiologies 69
Transition of idiopathic CD4 + lymphocytopenia into mycosis fungoides? 66
The Glycosphingolipid GD2 as an Effective but Enigmatic Target of Passive Immunotherapy in Children with Aggressive Neuroblastoma (HR-NBL) 61
Essential thrombocytemia progressing to Ph+ chronic myeloid leukemia with megakaryoblastic blasts, following anagrelide withdrawal 53
Totale 868
Categoria #
all - tutte 2.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020176 0 23 7 11 19 19 16 20 18 12 23 8
2020/2021107 6 13 1 13 9 9 6 6 16 12 3 13
2021/202250 1 3 2 4 3 2 1 3 4 3 3 21
2022/2023140 23 16 1 7 18 26 15 7 21 2 2 2
2023/2024148 12 22 23 15 15 9 4 23 7 10 7 1
2024/202520 16 4 0 0 0 0 0 0 0 0 0 0
Totale 868